This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) — DaVita Clinical Research® (DCR®), a provider of clinical research services focused on kidney care as well as a multitude of specialty therapeutic…
DENVER, May 11, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease…
DENVER, May 10, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease…
DENVER, May 03, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease…
DENVER, May 02, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE:DVA) today announced results for the quarter ended March 31, 2011. Net income attributable to DaVita Inc. for the quarter ended March 31,…